COATED MEDICAL DEVICES EMBOLIZATION

Brand Owner (click to sort) Address Description
CELONOVA CeloNova BioSciences, Inc. 8023 Vantage Drive, Suite 1500 San Antonio TX 78230 Coated medical devices for embolization;
EMBOZENE VARIAN MEDICAL SYSTEMS, INC. 3100 Hansen Way Palo Alto CA 94304 Coated medical devices for embolization, namely, embolic microspheres for embolization and syringes; Coated medical devices for embolization, namely, embolic microspheres for embolization in the form of particles; Coated medical devices for embolization, namely, embolic devices in the form of particles to slow or block blood flow for mediating devascularizations; Coated medical devices for embolization, namely, embolic devices in the form of particles to block blood flow throughout the vasculature system of mammals; Coated medical devices for embolization, namely, embolic devices in the form of particles to treat hemorrhages, arteriovenous malformations, hemangioendothelioma, cerebral aneurysms, muscle hypertrophy, hypertrophic cardiomyopathy, gastrointestinal bleeding, trauma, epistaxis, bone cysts, bone metastases, vertebral metastases, varicoceles, congenital hemangioma, artiovenous fistulae, vena cava, vascular anomalies, priapism, prostatic hematuria, hemoptysis, hemorrhagic cystitis, and post-partum hemorrhage; Coated medical devices for embolization, namely, embolic devices in the form of particles to prevent or reduce blood flow through any tissue or organ of interest in order to reduce the growths of malignant cells, tumors, lesions, hepatocellular carcinoma, and fibroids; Coated medical devices for embolization, namely, embolic devices in the form of particles to treat vascular conditions;
EMBOZENE CELONOVA BIOSCIENCES GERMANY GMBH SOFLINGER STR. 100 89077 ULM Germany Coated medical devices for embolization, namely, embolic microspheres for embolization and syringes; Coated medical devices for embolization, namely, embolic microspheres for embolization in the form of particles; Coated medical devices for embolization, namely, embolic devices in the form of particles to slow or block blood flow for mediating devascularizations; Coated medical devices for embolization, namely, embolic devices in the form of particles to block blood flow throughout the vasculature system of mammals; Coated medical devices for embolization, namely, embolic devices in the form of particles to treat hemorrhages, arteriovenous malformations, hemangioendothelioma, cerebral aneurysms, muscle hypertrophy, hypertrophic cardiomyopathy, gastrointestinal bleeding, trauma, epistaxis, bone cysts, bone metastases, vertebral metastases, varicoceles, congenital hemangioma, artiovenous fistulae, vena cava, vascular anomalies, priapism, prostatic hematuria, hemoptysis, hemorrhagic cystitis, and post-partum hemorrhage; Coated medical devices for embolization, namely, embolic devices in the form of particles to prevent or reduce blood flow through any tissue or organ of interest in order to reduce the growths of malignant cells, tumors, lesions, hepatocellular carcinoma, and fibroids; Coated medical devices for embolization, namely, embolic devices in the form of particles to treat vascular conditions;
EMBOZENE Imed Devices, Inc. 145 Torrey Pines Court Newnan GA 30265 Coated medical devices for embolization, namely, embolic microspheres for embolization and syringes; Coated medical devices for embolization, namely, embolic microspheres for embolization in the form of particles; Coated medical devices for embolization, namely, embolic devices in the form of particles to slow or block blood flow for mediating devascularizations; Coated medical devices for embolization, namely, embolic devices in the form of particles to block blood flow throughout the vasculature system of mammals; Coated medical devices for embolization, namely, embolic devices in the form of particles to treat hemorrhages, arteriovenous malformations, hemangioendothelioma, cerebral aneurysms, muscle hypertrophy, hypertrophic cardiomyopathy, gastrointestinal bleeding, trauma, epistaxis, bone cysts, bone metastases, vertebral metastases, varicoceles, congenital hemangioma, artiovenous fistulae, vena cava, vascular anomalies, priapism, prostatic hematuria, hemoptysis, hemorrhagic cystitis, and post-partum hemorrhage; Coated medical devices for embolization, namely, embolic devices in the form of particles to prevent or reduce blood flow through any tissue or organ of interest in order to reduce the growths of malignant cells, tumors, lesions, hepatocellular carcinoma, and fibroids; Coated medical devices for embolization, namely, embolic devices in the form of particles to treat vascular conditions;
EMBOZENE Polyzenix GmbH Soeflinger Strabe 100 89077 ULM Germany Coated medical devices for embolization, namely, embolic microspheres for embolization and syringes; Coated medical devices for embolization, namely, embolic microspheres for embolization in the form of particles; Coated medical devices for embolization, namely, embolic devices in the form of particles to slow or block blood flow for mediating devascularizations; Coated medical devices for embolization, namely, embolic devices in the form of particles to block blood flow throughout the vasculature system of mammals; Coated medical devices for embolization, namely, embolic devices in the form of particles to treat hemorrhages, arteriovenous malformations, hemangioendothelioma, cerebral aneurysms, muscle hypertrophy, hypertrophic cardiomyopathy, gastrointestinal bleeding, trauma, epistaxis, bone cysts, bone metastases, vertebral metastases, varicoceles, congenital hemangioma, artiovenous fistulae, vena cava, vascular anomalies, priapism, prostatic hematuria, hemoptysis, hemorrhagic cystitis, and post-partum hemorrhage; Coated medical devices for embolization, namely, embolic devices in the form of particles to prevent or reduce blood flow through any tissue or organ of interest in order to reduce the growths of malignant cells, tumors, lesions, hepatocellular carcinoma, and fibroids; Coated medical devices for embolization, namely, embolic devices in the form of particles to treat vascular conditions;
MICRO-BLAND EMBOLIZATION CeloNova BioSciences, Inc. 8023 Vantage Drive, Suite 1500 San Antonio TX 78230 Coated medical devices for embolization, namely polyphosphazene-coated delivery devices, polyphosphazene-coated particles, polyphosphazene-coated color-calibrated particles, polyphosphazene-coated radiopaque particles, polyphosphazene-coated tubings, polyphosphazene-coated fibers, polyphosphazene-coated sheets, polyphosphazene-coated meshes, polyphosphazene-coated adhesives, polyphosphazene-coated pledgets, polyphosphazene-coated coils, and polyphosphazene-coated gels;
MICROBLAST EMBOLIZATION CeloNova BioSciences, Inc. 8023 Vantage Drive, Suite 1500 San Antonio TX 78230 Coated medical devices for embolization, namely, polyphosphazene-coated delivery devices for eluting various pharmaceutical and/or biologic agents, polyphosphazene-coated particles for eluting various pharmaceutical and/or biologic agents, polyphosphazene-coated color-calibrated particles for eluting various pharmaceutical and/or biologic agents, polyphosphazene-coated radiopaque particles for eluting various pharmaceutical and/or biologic agents, polyphosphazene-coated tubings, polyphosphazene-coated fibers for eluting various pharmaceutical and/or biologic agents, polyphosphazene-coated sheets, polyphosphazene-coated meshes for eluting various pharmaceutical and/or biologic agents, polyphosphazene-coated adhesives, polyphosphazene-coated pledgets for eluting various pharmaceutical and/or biologic agents, polyphosphazene-coated coils for eluting various pharmaceutical and/or biologic agents, and polyphosphazene-coated gels for eluting various pharmaceutical and/or biologic agents;MICRO BLAST EMBOLIZATION;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. In addition to reducing or substantially eliminating a biological organism's reaction to the introduction of the medical device to the organism, the medical device in combination with one or more therapeutic drugs, agents and/or compounds may be utilized to treat various vascular diseases, for example, restenosis and vulnerable plaque. In the case of vulnerable plaque, one or more drugs, agents or compounds may be utilized to treat the various aspects of vulnerable plaque and these drugs, agents and/or compounds may be released with a given release profile for the most effective treatment. Various materials and coating methodologies may be utilized to maintain the drugs, agents or compounds on the medical device until delivered and positioned.